Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
HPV Vaccine,270μg/1.0ml
BIOLOGICAL
2 trials
Sponsors
Xiamen University
Conditions
Cervical Cancer
Condylomata Acuminata
Phase 1
Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
Completed
NCT03813940
Xiamen University
Cervical Cancer, Condylomata Acuminata
Start: 2019-01-03
End: 2021-04-01
Updated: 2021-04-08
Phase 2
Immunogenicity Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
Completed
NCT03935204
Xiamen University
Cervical Cancer, Condylomata Acuminata
Start: 2019-05-13
End: 2021-04-01
Updated: 2021-04-08
Related Papers
Safety and immunogenicity of an <i>Escherichia coli</i>-produced 9-valent human papillomavirus L1 virus-like particle vaccine (types 6/11/16/18/31/33/45/52/58) in healthy adults: an open-label, dose-escalation phase 1 clinical trial.
2023-03-13
5 citations